China Cord Blood reported 149.72M in Operating Profit for its fourth fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Cerus CERS:US $ -9848000 2.89M
China Cord Blood CO:US 149.72M 10.73M
Concord Medical Services Hldg CCM:US -274410000 90.5M
Cytori Therapeutics CYTX:US $ -3926000 13K
Enzo Biochem ENZ:US $ -3.14M 1.21M
Mednax MD:US $ -17.91M 85.91M